My WebLink
|
Help
|
About
|
Sign Out
Home
Browse
Search
COMPLIANCE INFO_2019
EnvironmentalHealth
>
EHD Program Facility Records by Street Name
>
K
>
KETTLEMAN
>
2355
>
2200 - Hazardous Waste Program
>
PR0541026
>
COMPLIANCE INFO_2019
Metadata
Thumbnails
Annotations
Entry Properties
Last modified
1/18/2022 2:22:51 PM
Creation date
1/18/2022 1:23:10 PM
Metadata
Fields
Template:
EHD - Public
ProgramCode
2200 - Hazardous Waste Program
File Section
COMPLIANCE INFO
FileName_PostFix
2019
RECORD_ID
PR0541026
PE
2247
FACILITY_ID
FA0023488
FACILITY_NAME
CVS PHARMACY #16294
STREET_NUMBER
2355
Direction
W
STREET_NAME
KETTLEMAN
STREET_TYPE
LN
City
LODI
Zip
95242
CURRENT_STATUS
01
SITE_LOCATION
2355 W KETTLEMAN LN STE B
QC Status
Approved
Scanner
SJGOV\kblackwell
Tags
EHD - Public
There are no annotations on this page.
Document management portal powered by Laserfiche WebLink 9 © 1998-2015
Laserfiche.
All rights reserved.
/
107
PDF
Print
Pages to print
Enter page numbers and/or page ranges separated by commas. For example, 1,3,5-12.
After downloading, print the document using a PDF reader (e.g. Adobe Reader).
View images
View plain text
V CVSHealth <br /> Ms . Florido <br /> March 8 , 2019 <br /> Page 3 <br /> 3 . EPA carefully assessed whether destruction of empty warfarin containers is warranted <br /> and ultimately determined that destruction is not necessary. Although EPA ' s proposed <br /> rule would have required destruction of empty containers , EPA ultimately did not finalize <br /> the requirement to destroy the empty containers prior to disposal , given the potential for <br /> worker safety concerns if required to crush or shred the containers . <br /> We emphasize the above points from the Pharm Rule because EPA carefully considered <br /> whether residue and empty containers should be managed as hazardous (or acute hazardous) <br /> waste . Based on (i) data (such as the studies that EPA reviewed) supporting the conclusion that <br /> very little residue remains in containers after the pharmaceuticals are dispensed , and (ii) for <br /> policy reasons (such as avoiding sewering of residues after triple-rinsing) , EPA determined that <br /> it is not appropriate to manage the residues or containers as hazardous (or acute) hazardous <br /> waste . <br /> California. We are aware that prior to EPA ' s publication of the Pharm Rule , DTSC <br /> issued a December 24 , 2015 interpretation rejecting EPAs November 4 , 2011 memorandum <br /> regarding empty containers . DTSC interpreted California' s regulations as more stringent than <br /> federal regulations and stated : "The distinction between the regulations is that the federal <br /> regulation specifically addresses the ` Residues of hazardous waste in empty containers ' . . . and <br /> California' s regulation addresses the ` Contaminated Containers ' as whole entities . " <br /> The DTSC letter quoted California Code of Regulations , title 22 , section 66261 . 7(r) : <br /> Any container, or inner liner removed from a container, which previously <br /> held a hazardous material , including but not limited to hazardous waste , and which <br /> is not empty as defined in subsection [ . . . ] (d) of this section, . . . shall be managed <br /> as a hazardous waste in accordance with this division and Chapter 6 . 5 of Division <br /> 20 of the Health and Safety Code (commencing with Section 25100) . <br /> (Emphasis added) . DTSC further stated : <br /> When DTSC observes a hazardous waste that is comprised of non- empty <br /> containers having RCRA P - listed hazardous waste residues inside them, DTSC <br /> considers the entire container and residue combination as " the hazardous waste " <br /> that must be properly managed to protect human health and the environment . <br /> Accordingly, generators must include the weight of the container and not just the <br /> mass of container residue when computing the amount of acute hazardous waste <br /> generated (i . e . handling each residue and its associated container as a whole entity <br /> of hazardous waste) . (Cal . Code Regs . , tit . 225 § 66261 . 100 , subd . (a) (2) . ) <br /> DTSC reaffirmed its position regarding empty containers in a letter dated August 2 , 2018 . <br /> We do not dispute that the California regulatory language is somewhat different than federal <br /> regulations . However, there is an interpretation much more appropriate than DTSC ' s prior <br /> �; pharmacy / caremark / minute clinic / specialty <br />
The URL can be used to link to this page
Your browser does not support the video tag.